# MagDI Australia Study

> **NCT06473831** · NA · ACTIVE_NOT_RECRUITING · sponsor: **GT Metabolic Solutions, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DEVICE:** Magnet System, DI Biofragmentable

## Key facts

- **NCT ID:** NCT06473831
- **Lead sponsor:** GT Metabolic Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-13
- **Primary completion:** 2025-09-04
- **Final completion:** 2026-06-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06473831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06473831, "MagDI Australia Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06473831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*